Connect with us

Business

Morison gearing to re-shape pharmaceutical industry in SL by 2030

Published

on

Morison’s LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant in Homagama

Sri Lanka’s pharma industry with 1959-roots still producing only 15% of national requirement

Locally manufactured drugs have only 5% market share in private pharma market

Morison to compete with foreign brands with the commencement of commercial manufacturing

by Sanath Nanayakkare

It may be a long journey ahead, but we are going to accomplish it with the support of our science-driven, passionate, young team employed at our pharmaceutical manufacturing plant in Homagama, Dinesh Athapaththu, MD at Morison PLC told the media recently.

He said so while addressing a media roundtable at the LKR 4 billion worth state-of-the-art pharmaceutical manufacturing plant operating with minimum human involvement and maximum automation.

“We have embarked on a journey upstream of changing the landscape of the pharma manufacturing industry in Sri Lanka in order to make premium healthcare affordable for everyone,” he said.

“Healthcare is in the news for all the wrong reasons. Some Sri Lankan companies like Morison are trying to take the pharmaceutical industry to the next level after decades of stagnation. However, it is not receiving positive media attention, and therefore, the general public of the country as well as many doctors don’t know what Morison is doing to make this crucial investment work for Sri Lanka.

It has been more than three years since we made this investment and most of our resources still go into product development. Sri Lanka commenced pharmaceutical manufacturing in 1959, but it is still manufacturing just 15% of the national requirement whereas our neigbouring countries are far ahead of us in national supply volumes and export volumes.

“India, Pakistan, Bangladesh and Sri Lanka commenced pharma manufacturing in the 1950s which means pharma manufacturing in these countries got off the ground around the same time in history. In Sri Lanka, that feat was achieved by J.L Morison Son & Jones (Ceylon) PLC. Their facility at Aluth Mawatha, Mutwal became one of the pioneers of generic pharmaceutical manufacturing in Sri Lanka. However, 65 years on, Sri Lanka is still producing only 15% of its national medicine requirement whereas India is self-sufficient plus USD 20 billion worth exports, Bangladesh 95% self-sufficient plus exports worth USD 3 billion, Pakistan 70% self-sufficient plus exports worth USD 5 billion.

Morison enhancing the skill-set of young science and pharma graduates in Sri Lanka

“Sri Lanka’s total pharmaceutical market is estimated at about USD 600 million where 40% of that drugs value is dispensed through government hospitals while 60% is dispensed by private pharmacies. Only 25% of the total 15% locally manufactured pharmaceuticals are dispensed by the government. Most local manufacturers focus on supplying this 25% requirement to the government.

On the other hand, in the private market where doctor-prescribed brands are sold, the locally manufactured products have only a 5% market share, meaning 95% of the products sold in the private market are imported drugs. Having studied this, Morison decided to try and change things around even at this late stage by becoming a manufacturer of branded drugs of international standards in addition to being a bulk generic supplier to the government.”

Dinesh Athapaththu Managing Director at Morison

“Before we built the new plant in Homagama, we went to India and Pakistan to see the pharmaceutical plants there. We realized that we have an issue with the absence of high quality plants in Sri Lanka to go out and promote our products among doctors and private pharmacies. It was evident that we needed to bring high quality pharma manufacturing standards into the country in order to be able to manufacture drugs of the highest quality, safety and efficacy standards such as EU GMP. So we made a bold investment of LKR 4 billion to build this plant. We have been running the plant in compliance with WHO GMP (Good Manufacturing Practice) and EU GMP standards.”

‘Morison decided to take a long term view of this industry and enter the private market, without solely depending on government supplies which could be subject to policy changes from time to time. Therefore, our committed mission now is building a credible pharmaceutical brand which can readily compete with reputed imported pharma brands built on a patient-centric approach.”

“Indian pharma is in a good position today after about 60 -65 years’ of dedication. In Sri Lanka, proper pharmaceutical manufacturing has not significantly evolved. So we have to make necessary changes to transform this industry. For that, primarily we need to take a long term view of sustainable growth and subsequently about the return on investment. Our shareholders are being patient and supportive of our strategy.

We need to attract a lot of qualified young people into the industry to come and work because they will grow with the industry as we are gearing to make a notable impact in the pharmaceutical industry in Sri Lanka. be the best pharma brand in Sri Lanka by 2030, and effectively compete with foreign brands. At our Homagama factory, the average age of our workforce is around 30 years. The beauty of that is; in ten years, the most qualified Sri Lankan pharmaceutical manufacturing personnel will be around 40-years old,” a confident Dinesh said.

J.L. Morison Son & Jones (Ceylon) PLC was acquired by Hemas Holdings PLC in 2013, and today it is re-branded as Morison, retaining a sense of that historical legacy.

Morison’s Homagama manufacturing facility at present manufactures five drugs and has developed about 26 drugs out of which 10- 12 are in NMRA for registration and the rest are to be submitted for registration.

Morison is planning to submit for accreditation for their Homagama facility once it fulfills the complex European procedures, after which Morison’s products will have easier access to lucrative foreign markets, thereby earning much needed foreign currency for Sri Lanka.



Business

Global regulators convene in Colombo for key IOSCO enforcement and cooperation discussions

Published

on

Dignitaries at the wide-ranging discussions.

The Securities and Exchange Commission of Sri Lanka (SEC) successfully hosted a series of high-level meetings of the International Organization of Securities Commissions (IOSCO), bringing together leading securities regulators and enforcement officials from around the world to discuss emerging regulatory challenges, strengthen international cooperation, and enhance collective efforts to combat cross-border securities market misconduct.

The meetings, held at the Hilton Colombo from 13 to 16 October 2026, included sessions of the IOSCO Enforcement and Cooperation Committee and its Screening Group (Committee 4/SG), as well as meetings of the Monitoring Group and the Steering Committee. The event attracted approximately 50 senior representatives from securities regulators and exchanges across several jurisdictions, including Australia, Japan, the United States, the United Kingdom, France, Italy, Canada, New Zealand, India, Germany, Belgium, Singapore, China and Spain, reflecting the global significance of the discussions and the growing importance of international regulatory collaboration.

Welcoming delegates to Sri Lanka, Senior Professor D.B.P.H. Dissabandara, Chairman of the SEC, emphasized the critical role of international cooperation in safeguarding market integrity and investor confidence in an increasingly interconnected financial landscape.

“No regulator can effectively address cross-border misconduct in isolation. The speed with which information, transactions and illicit activities can move across borders requires an equally coordinated and timely regulatory response. Strong international cooperation, effective information sharing and mutual trust among regulators are essential to maintaining fair, transparent and resilient capital markets,” he stated.

The discussions focused on a range of enforcement and cooperation matters, including mechanisms for enhancing cross-border information exchange, strengthening investigative collaboration among regulators, addressing increasingly sophisticated forms of securities fraud and market abuse, and promoting the effective implementation of international standards and best practices. Participants also exchanged experiences and insights on emerging enforcement challenges arising from technological developments, digitalization of financial services, and increasingly interconnected global markets.

IOSCO is recognized as the leading international body that brings together the world’s securities regulators and serves as the global standard setter for securities regulation. Through its policy work and cooperative initiatives, IOSCO plays a central role in promoting investor protection, ensuring that markets are fair, efficient and transparent, reducing systemic risk, and strengthening confidence in capital markets worldwide.

Sri Lanka has maintained a strong and active relationship with IOSCO for more than three decades. The SEC became an Ordinary Member of IOSCO in 1993 and has been a signatory to the IOSCO Multilateral Memorandum of Understanding (MMoU) since 2004. The MMoU is the internationally recognised benchmark for cooperation and information sharing among securities regulators and serves as a critical tool in facilitating cross-border investigations and enforcement actions.

Continue Reading

Business

Pan Asia Bank partners Ideal Motors to offer leasing solutions

Published

on

Representatives of both parties are seen exchanging the agreement (Standing from left to right) Officials from Ideal motors: Trevene Ferdinand, AGM - Corporate/Tender; Dinesh Manage, Business Development Manager; Kasun Fernando, General Manager - Commercial Vehicles; Nimisha Welgama, Director – Legal and Corporate Affairs; Officials from Pan Asia Bank: Naleen Edirisinghe, Director/CEO; Yohan Ebell, Head of Retail Credit; Sudharshana Hettiarachchi, Officer in Charge – Leasing; and Kanchana Kannangara, National Sales Manager – Leasing.

Pan Asia Bank recently entered into a one-year Memorandum of Understanding (MOU) with Ideal Motors (Pvt) Ltd, creating a new financing avenue for customers purchasing vehicles from the authorised Mahindra dealer. The strategic partnership will enable customers of Ideal Motors to access leasing facilities from Pan Asia Bank, making vehicle financing more convenient while supporting their mobility and business requirements. The agreement also provides an opportunity for the Bank to expand its leasing portfolio and strengthen its presence in Sri Lanka’s vehicle financing market.

Ideal Motors is the authorised dealer for the Mahindra vehicle range in Sri Lanka, including the Mahindra Bolero CPU Truck and Scorpio Jeep/Pickup. The vehicles cater to a range of requirements, from commercial and business applications to personal mobility, making accessible financing an important part of the purchasing decision.

The Bank’s vehicle leasing facilities are designed to simplify the financing process, with convenient repayment options and professional support to help customers select a solution suited to their requirements. For customers, the arrangement brings vehicle selection and financing closer together, reducing the need to navigate the two processes separately.

“Our partnership with Ideal Motors enables us to bring financing closer to customers at the point of vehicle purchase. We remain focused on providing convenient and flexible leasing solutions that support both personal mobility and the needs of businesses,” said Naleen Edirisinghe, Director/CEO of Pan Asia Bank.

Pan Asia Bank and Ideal Motors will work closely during the one-year partnership to maximise business opportunities and deliver a seamless financing experience to customers. The collaboration is expected to strengthen both organisations’ ability to respond to demand for commercial and personal vehicles while creating greater value for customers.

Yohan Ebell, Head of Retail Credit, Pan Asia Bank, said: “Through this partnership, we aim to make vehicle financing simpler and more accessible, with leasing solutions designed to meet the varied requirements of Ideal Motors’ customers.”

The collaboration also reflects Pan Asia Bank’s commitment to building partnerships that make financial services more accessible and responsive to the needs of individuals and businesses.

Pan Asia Bank has established a growing presence in vehicle financing, offering leasing solutions designed around customer convenience and flexibility. Its leasing proposition is supported by a nationwide branch network and a customer-focused approach, enabling customers to obtain guidance on financing options while completing their vehicle purchase.

Continue Reading

Business

Heritance Hotels and Resorts secures four wins at World Travel Awards 2026

Published

on

Heritance Hotels and Resorts has secured four distinguished titles at the World Travel Awards 2026, with three national awards recognising its Sri Lankan properties and an international title for Heritance Aarah in the Maldives.

The three Sri Lankan titles recognise Heritance Tea Factory as Sri Lanka’s Leading Heritage Hotel 2026, Heritance Ahungalla as Sri Lanka’s Leading Luxury Hotel 2026, and Heritance Kandalama as Sri Lanka’s Leading Wedding Hotel 2026. Heritance Aarah was named the Indian Ocean’s Leading All-Inclusive Resort 2026.

Internationally recognised within the global travel and tourism industry, the World Travel Awards celebrate excellence across hotels, resorts, and destinations. Recognition at this level affirms the quality, distinctiveness, and consistency of the experiences delivered by Heritance Hotels and Resorts.

Continue Reading

Trending